LogicBio Therapeutics, Inc. (LOGC) Social Stream
LOGICBIO THERAPEUTICS INC (LOGC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LOGICBIO THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-11 | 5 | $20.001 | $15 | $17.5 | $2.07 | 745.41% |
| 2021-11-19 | 6 | $20.001 | $8 | $15 | $2.07 | 624.64% |
| 2021-12-26 | 6 | $16 | $8 | $14.2 | $2.07 | 585.99% |
| 2022-02-02 | 6 | $16 | $6 | $12.2 | $2.07 | 489.37% |
| 2022-05-17 | 4 | $16 | $4 | $11 | $2.07 | 431.4% |
| 2022-08-22 | 3 | $16 | $2.5 | $8.833 | $2.07 | 326.71% |
The Trend in the Analyst Price Target
LOGC's average price target has moved down $11.12 over the prior 27 months.
LOGC reports an average of 1,777.67% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-26 | 6 | 16 | 8.0 | 14.200 | 2.470 | 474.9% |
| 2022-02-02 | 4 | 16 | 6.0 | 11.500 | 0.677 | 1598.67% |
| 2022-05-17 | 4 | 16 | 4.0 | 11.000 | 0.425 | 2488.24% |
| 2022-08-22 | 3 | 16 | 2.5 | 8.833 | 0.380 | 2224.47% |
| 2022-08-22 | 3 | 16 | 2.5 | 10.625 | 0.380 | 2696.05% |
LOGC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
LOGC's average broker recommendation rating improved by 0.1 over the prior 14 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LOGC as an investment opportunity.
- In terms of how LOGICBIO THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1021.91% of that group.
- To contextualize these metrics, consider that out of all US stocks, LOGICBIO THERAPEUTICS INC's average analyst price target is higher than 168.02% of them.
- In terms of how LOGICBIO THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -668.52% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, LOGICBIO THERAPEUTICS INC's number of analysts covering the stock is higher than 300.8% of them.
In the Pharmaceutical Products industry, GRTS, AUTL, and SRRK are the three stocks most similar to LOGICBIO THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is LOGC a Buy, Hold or Sell? See the POWR Ratings now!